J. Pultz

发表

Sigma-1 receptors modulate functional activity of rat splenocytes

S. Wolfe, B. B. Whitlock, Yuhong Liu, 1995, Journal of Neuroimmunology.

Clinical Improvement and tolerability is maintained long term in elderly patients with psychotic disorders treated with quetiapine

P. Tariot, C. Salzman, P. Yeung, 1999, European Neuropsychopharmacology.

Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis

C. Pozzilli, P. Vermersch, A. Maghzi, 2022, JAMA network open.

Effects on C3H mouse mammary cancer of changing from a high fat to a low fat diet before, at, or after puberty.

J. Silverman, J. Powers, P. Stromberg, 1989, Cancer research.

Clinicopathologic findings in dogs with renal amyloidosis: 59 cases (1976-1986).

J. Powers, M. Tarr, S. Dibartola, 1989, Journal of the American Veterinary Medical Association.

Statistical comparison of dissolution curves.

R. Bartoszynski, E. Herderick, J. Powers, 2001, Pharmacological research.

Long-Term use of quetiapine in elderly patients with psychotic disorders.

P. Tariot, C. Salzman, P. Yeung, 2000, Clinical therapeutics.

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis

M. Valis, P. Huppke, A. Blaschek, 2021, Frontiers in Neurology.

Does cognitive function improve with quetiapine in comparison to haloperidol?

Alexander L. Miller, J. Csernansky, J. Newcomer, 2002, Schizophrenia Research.

Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder.

D. Sheehan, V. Coric, R. Marcus, 2009, Psychiatry (Edgmont (Pa. : Township)).

ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia.

L. Fabre, J. Malick, V. M. Jones, 1995, Clinical therapeutics.

Fluoxetine versus trazodone: efficacy and activating-sedating effects.

C. Beasley, B. Dornseif, M. Sayler, 1991, The Journal of clinical psychiatry.

Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.

G. Sachs, D. Crandall, R. Mcquade, 2007, The Journal of clinical psychiatry.

Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorder

T. Delmonte, A. Shekhar, D. Oren, 2010, Depression and anxiety.

Immune response to vaccines is maintained in patients treated with dimethyl fumarate

S. Sheikh, C. V. von Hehn, M. Edwards, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS).

R. Alroughani, Satish Eraly, N. Penner, 2018, Pediatric neurology.

Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorder

T. Delmonte, A. Shekhar, D. Oren, 2010, Depression and anxiety.